Background People with chronic kidney disease (CKD) have an increased risk of stroke but
the magnitude of increased risk and the independent effects of glomerular filtration rate …

Although reducing low-density lipoprotein-cholesterol (LDL-C) levels with lipid-lowering
agents (statins) decreases cardiovascular disease (CVD) risk, a substantial residual risk (up …

Background: Heart failure (HF) is a leading cause of hospitalization throughout the world,
and the mortality rate remains elevated. HF is frequently complicated by acute kidney injury …

Objectives Our aim was to determine if chronic kidney disease (CKD) occurring in childhood
impairs the normally vasoprotective functions of high-density lipoproteins (HDLs). Materials …

Background Global longitudinal strain (GLS) has emerged as a superior method for
detecting left ventricular (LV) systolic dysfunction compared to ejection fraction (EF) on the …

Objectives Endocan is a new marker of endothelial cell activation that mediates adhesion of
leukocytes into endothelium. Soluble intercellular (sICAM-1) and vascular cellular (sVCAM …

Cardiovascular disease is the leading cause of death and morbidity in people with chronic
kidney disease, but there are few evidence-based treatments for reducing cardiovascular …

Objectives The relationship between low estimated glomerular filtration rate (eGFR) and the
outcome of ischemic stroke remains controversial, despite the close association between …

Objectives Chronic renal disease (CRD) accelerates atherosclerosis and cardiovascular
calcification. Statins reduce low-density lipoprotein-cholesterol levels in patients with CRD …

This review summarizes the current methods for the functional assessment of vascular
damage (eg, assessment of endothelial function, measurement of pulse wave velocity, and …